Citations

Clear

116 citation(s) found for "Davis, Mark".

PATCH TESTING TO THE DUST MITE ( DERMATOPHAGOIDES MIX, 0.1% PREPARATION): HIGH RATE OF REACTION IN BOTH ATOPIC AND NONATOPIC PATIENTS
Davis, Mark D. P. , Cheng, Janet F., Yiannias, James A. , Davis, Mark D.P.

Mayo Clinic

Dermatitis® | March 2, 2026 | Volume: 16 | Issue: 2 | Pages: 99-100

10.2310/derm.1.2005.2082 Get It

BACK TO BASICS: IN CALCULATING PATCH TEST REACTIONS, SHOULD MACULAR ERYTHEMA AND LESSER REACTIONS BE INCLUDED?
Davis, Mark D.P., Yiannias, James A. , Davis, Mark D.P.

Mayo Clinic

Dermatitis® | March 2, 2026 | Volume: 16 | Issue: 2 | Pages: 98-98

10.2310/derm.1.2005.2078 Get It

Low Yield for Extended Reading of Patch Tests with Topical Corticosteroids
Davis, Mark D. P., Richardson, Donna M., Farmer, Sara A., Davis, Mark D.P.

Mayo Clinic

Dermatitis® | March 2, 2026 | Volume: 16 | Issue: 3 | Pages: 124-126

10.2310/derm.1.2005.2103 Get It

Patch-Test Reactions to Thioureas Are Frequently Relevant
Comfere, Nneka I. , Davis, Mark D. P., Fett, Debra D., Davis, Mark D.P.

Mayo Clinic

Dermatitis® | March 2, 2026 | Volume: 16 | Issue: 3 | Pages: 121-123

10.2310/derm.1.2005.2102 Get It

Results of Patch Testing to a Corticosteroid Series: Experience with 1000 Patients at Mayo Clinic
Davis, Mark D.P., Farmer, Sara A., Davis, Mark D.P.

Mayo Clinic

Dermatitis® | March 2, 2026 | Volume: 17 | Issue: 2 | Pages: 102-103

10.2310/6620.2006.x0002x Get It

What Patients Remember after Patch Testing
Genebriera, Joseph, Scalf, Leigh Ann, Davis, Mark D.P., Farmer, Sara A., Davis, Mark D.P. , Farmer, Sara A.

Mayo Clinic

Dermatitis® | March 2, 2026 | Volume: 17 | Issue: 2 | Pages: 101-102

10.2310/6620.2006.x0002u Get It

Patient Survey Results from Patch Testing at the Mayo Clinic
Scalf, Leigh Ann, Davis, Mark D.P., Farmer, Sara A., Davis, Mark D.P. , Farmer, Sara A.

Mayo Clinic

Dermatitis® | March 2, 2026 | Volume: 17 | Issue: 2 | Pages: 101-101

10.2310/6620.2006.x0002t Get It

Venous Abnormalities in Biopsy-confirmed Lipodermatosclerosis
Garimella, Vishal, Mukosera, George Tinotenda, Liedl, David , Todd, A., Davis, Mark D.P. , Rooke, Thom W., Alavi, A., Liedl, David A, Davis, Mark Denis P., Garimella, Vishal, Mukosera, George T. , Rooke, Thom W.

Mayo Clinic

Advances in Skin & Wound Care | February 6, 2026 | Volume: 39 | Issue: 3 | Pages: 141-144

10.1097/asw.0000000000000421 | PMID 41649308 Get It

BACKGROUND: Lipodermatosclerosis (LDS) is a type of sclerosing panniculitis that predominantly involves the lower extremities and is characterized by erythema, hemosiderin pigmentation, and sclerotic skin lesions. LDS is a common reason for specialty consultations across clinical settings, including dermatology, vascular medicine, and occasionally the emergency department or internal medicine services. METHODS: To further evaluate the prevalence of venous hypertension in patients with LDS at the authors’ institution, they retrospectively reviewed the findings of lower extremity Doppler ultrasonography with or without segmental pressure (ie, venous ultrasonography) performed for adult patients with biopsy-confirmed LDS who were treated at the Clinic from January 1, 2000, through September 30, 2022. RESULTS: A total of 430 patients were included in the study. Venous ultrasonography findings were abnormal for 327 (76.0%) patients, whereas the other 103 (23.9%) patients had normal findings. Venous hemodynamics studies, including air plethysmography and continuous-wave Doppler ultrasonography, were performed for 33 patients with normal venous ultrasonography findings. Of these patients, 7 had mild valvular incompetence, 12 had abnormal calf muscle pump function, and 2 had pulsatility (backflow in the peripheral vein with elevated right atrial pressure) evident on continuous-wave Doppler ultrasonography. CONCLUSIONS: Overall, the findings extend previous observations that venous abnormalities are commonly present in patients with LDS and may contribute to its pathogenesis. However, a few patients with LDS have normal venous hemodynamics, which suggests that other factors also contribute to LDS pathogenesis.
Evaluating Copositivity Patterns in Fragrance/Botanical Patch Testing through Hierarchical Clustering and Network Analysis
Yang, Yul W. , Yiannias, James A. , Yiannias, James A., Davis, Mark D.P., Hall, Matthew R. , Voelker, Dayne , Youssef, Molly J. , Hall, Matthew R , Voelker, Dayne H, Yiannias, James A.

Mayo Clinic

Dermatitis® | June 18, 2025 | Volume: 37 | Issue: 1 | Pages: 61-67

10.1089/derm.2024.0442 | PMID 40533092 Get It

Abstract: Background: Fragrances/botanicals are ubiquitous allergens. Patients allergic to one fragrance/botanical are frequently sensitive to other fragrances/botanicals and are typically counseled to avoid all fragrances/botanicals. However, broad avoidance of all fragrances/botanicals may not be clinically necessary. Objectives: We examined copositivity patterns in fragrance/botanical patch testing. Methods: The Mayo Clinic patch test database was queried for pairwise copositivity rates for fragrances/botanicals between 1997 and 2022, representing a total of 43 allergens. Data analyzed included 4706 positive reactions out of 252,485 total patches applied to 15,864 patients. After background correction for general positivity, copositivity rates were organized through unsupervised hierarchical clustering to determine copositivity subgroups and then evaluated through network analysis. Results: After background correction, clustering revealed distinct copositivity subgroups: Fragrance Mix I– Myroxylon pereirae –limonene hydroperoxides–linalool hydroperoxides; Compositae Mix–sesquiterpene lactone–parthenolide; Fragrance Mix II–Lyral; lichen acid mix–treemoss extract; menthol– Mentha piperita ; narcissus–dandelion; and Santalum album –trans-anethole–tea tree–lemongrass–clove–turpentine– Rosa damascena – Lavandula – Geranium – Cananga odorata –neroli–bergamot. In addition, there were further isolated intergroup copositivity reactions seen in network analysis. Conclusions: Background correction followed by hierarchical clustering demonstrated the fragrance/botanical group can be divided into multiple copositivity subgroups. Combined with network analysis, patients with a positive patch test to one fragrance/botanical allergen may be preferentially guided to use specific other fragrances/botanicals.
Trends in Patch Test Results With the Mayo Clinic Extended Standard Series: A 14-Year Retrospective Review (2010–2023)
Aristizabal-Torres, Miguel A., Youssef, Molly J. , Yang, Yul W. , Yiannias, James A. , Davis, Mark D.P. , Hall, Matthew R. , Torres, Miguel A. Aristizabal , Aristizabal, Miguel A , Youssef, Molly, Aristizabal, Miguel

Mayo Clinic

Dermatitis® | May 14, 2025 | Volume: 37 | Issue: 2 | Pages: 230-237

10.1089/derm.2025.0075 | PMID 40365644 Get It

Abstract: Background: Extended patch testing beyond the standard series is commonly performed in patients with allergic contact dermatitis. This broader testing allows for more precise and complete allergen identification, ultimately leading to improved clinical outcomes. Objective: To report the Mayo Clinic Contact Dermatitis Group (MCCDG) patch testing results using a custom extended series from 2010 to 2023. Methods: A retrospective review of patch testing results using the MCCDG extended standard series at the Mayo Clinic was conducted. Data from 2010 to 2023 were analyzed. Results: Patch testing with the extended standard series was performed in 3,767 unique patients, with a total of 3834 extended standard patch tests administered (81.8% in women, 18.2% in men). The top 5 allergens eliciting positive reactions were gold (I) sodium thiosulfate (10.4%), benzisothiazolinone (10.4%), carmine (9.4%), thimerosal (9.3%), and hydroperoxides of linalool (8.8%). Conclusions: The extended standard series expands the diagnostic scope for patients in whom the standard series incompletely identifies relevant allergens. Preservatives and fragrances remain among the most common sensitizers, emphasizing the need for ongoing allergen surveillance, periodic review, and updates to patch test series to enhance diagnostic accuracy and patient care.